News

A little bit of narcissism can make a leader. “Too much” can be a problem. On the nature of leadership from a psychological perspective.

The abuse of alcohol by patients with schizophrenia is a remarkably common phenomenon. Here: findings from a 6-month randomized trial of long-acting injectable versus oral risperidone in patients with schizophrenia and comorbid alcohol use disorder.

Intended for short-term use, this treatment is associated with specific diagnostic and symptom characteristics, with anhedonia being a stand-out.

Researchers looked into the efficacy and value of TMS for treatment-resistant depression.

There is an impressive array of presentations and speakers at an upcoming meeting, the only one in the country to address behavioral emergencies in the acute care setting.

If serotonin was once American psychiatry’s “high school crush,” the field now appears wedded to a more mature model of biological and psychosocial understanding.

There has probably never been a worse place and worse time to have a severe mental illness than now in the United States. How did we get into this mess?

With a consistent and evolving presence in the US, forensic psychiatry has grown increasingly complex, with many specialty areas under its subspecialty umbrella.

Psychiatrists should not be afraid to assess parenting issues and other stressors when treating depressed or psychotic parents of young children.

About 25% of children in the US live with only one parent; the fallout from contentious divorces often leaves them susceptible to any number of damaging scenarios.

This article reviews a wide array of medicolegal, risk management, regulatory, and forensic mental health issues in the older population, which is growing at an accelerated rate.

Reporting of symptoms that are beyond available medical evidence is a central feature of malingering and related conditions, making the clinical differentiation of these disorders a challenge.

This article focuses primarily on the issues facing a psychiatrist who has been retained as an expert witness in a will or trust contest involving claims of a lack of capacity.

Deficits in emotion recognition among at-risk patients may predict eventual transition to schizophrenia.

The stories of two psychiatrists who died recently-one who passed away gently at the end of a long life; the other died violently, much too soon.

A report on substance abuse and HIV research around the world.

The effects of climate change are severe and global, affecting world economies, triggering migrations and wars, and having profound effects on mental and physical health.

The views of mental health experts on changes in psychiatric theory and practice since World War II.

Comorbid medical symptoms, polypharmacy, and cognitive decline are hallmarks of depression in the fastest growing segment of the population.

An update on what happens in the brain when the mind is engaged in psychotherapy.

The Editor in Chief of Psychiatric Times discusses some of our new initiatives to bring readers the most up-to-date information in the field of psychiatry.

The clinical presentation and functional impacts of ADHD in adults vary greatly from their child and adolescent counterparts. Here: latest information on this complex topic.

A reminder that success in life requires paying attention to the basics, starting with showing up and hanging in there.

I want my patients to believe I consider Peabody’s advice before I see them, that I recognize our shared humanity...

A study has found that induction of slow waves during early non-rapid eye movement sleep may improve executive function in children with ADHD.

We are the richest nation in the history of the world and yet we provide the worst care ever conceived for the severely ill who most need it.

In addition to helping indiviiduals with PTSD, psychiatrists can play an active role in resolving trauma experienced by the country as a whole.

In the treatment of depression, clinicians are often faulted for failing to give an antidepressant medication at a high enough dose. What is high enough? Answering this question turns out to be tricky.

Striking findings on the relationship between stress and depression.

Flibanserin is a breakthrough. We will finally be able to talk to women with hypoactive sexual desire disorder about a treatment that has FDA approval.